Association of antinociceptive action of botulinum toxin type A with GABA-A receptor

Journal of Neural Transmission

Volumn 121, Issue 6, 2014, Pages 665-669

  Drinovac, V ^a   Bach Rojecky, L ^a   Lackovic Z ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Botulinum toxin type A; c Fos; Formalin induced pain; GABA; Neuropathic pain

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; BOTULINUM TOXIN A; FORMALDEHYDE; NEUROTOXIN; PROTEIN C FOS;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CISTERNA MAGNA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG MECHANISM; FORMALIN TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATORY PAIN; INTRAPLANTAR DRUG ADMINISTRATION; MALE; NEUROPATHIC PAIN; NONHUMAN; PARTIAL SCIATIC NERVE LIGATION INJURY; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; HYPERALGESIA; METABOLISM; PAIN; PAIN MEASUREMENT; SCIATICA; TOXICITY; WISTAR RAT;

ANIMALS; BICUCULLINE; BOTULINUM TOXINS, TYPE A; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; FORMALDEHYDE; HYPERALGESIA; NEUROTOXINS; PAIN; PAIN MEASUREMENT; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; SCIATICA;

EID: 84901831948     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1150-6     Document Type: Article

References (23)

1. Antal M, Petkó M, Polgár E, Heizmann CW, Storm-Mathisen J (1996) Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla. Neuroscience 3(2):509-518
2. Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M (2008) Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28:3689-3696
3. Aoki KR (2008) Future aspects of botulinum neurotoxins. J Neural Transm 115:567-573
4. Aoki KR, Francis J (2011) Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism Relat Disord Suppl 1:S28-S33
5. Bach-Rojecky L, Lacković Z (2009) Central origin of the antinociceptive action of the botulinum toxin type A. Pharmacol Biochem Behav 94:234-238
6. Bach-Rojecky L, Šalković-Petrišić M, Lacković Z (2010) Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effects after unilateral injection. Eur J Pharmacol 633:10-14
7. Bardoni R, Takatawa T, Tong CK, Choudhury P, Scherre G, MacDermott AB (2013) Pre- and postsynaptic inhibitory control in the spinal cord dorsal horn. Ann NY Acad Sci 1279:90-96
8. Drinovac V, Bach-Rojecky L, Matak I, Lacković Z (2013) Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A. Neuropharmacology 70:331-337
9. Favre-Guilmard C, Auguet M, Chabrier PE (2009) Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur J Pharmacol 617:48-53
10. Filipovic B, Matak I, Bach-Rojecky L, Lacković Z (2012) Central action of peripherally applied botulinum toxin type A on pain and dural extravasation in rat model of trigeminal neuropathy. PLoS One 7(1):e29803. doi: 10.1371/journal.pone.0029803
11. Jabbari B, Machado D (2011) Treatment of refractory pain with botulinum toxins - an evidence-based review. Pain Med 12(11):1594-1606
12. Lindenlaub T, Sommer C (2000) Partial sciatic nerve transection as a model of neuropathic pain: a qualitative and quantitative neuropathological study. Pain 89:97-106
13. Matak I, Bach-Rojecky L, Filipović B, Lacković Z (2011) Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 186:201-207
14. Matak I, Riederer P, Lacković Z (2012) Botulinum toxin's axonal transport from periphery to the spinal cord. Neurochem Int 61:236-239
15. Matteoli M, Pozzi D, Grumelli C, Condliffe SB, Frassoni C, Harkany T, Verderio C (2009) The synaptic split of SNAP-25: different roles in glutamatergic and GABAergic neurons? Neuroscience 158(1):223-230
16. Melin C, Jacquot F, Dallel R, Artola A (2013) Segmental disinhibition supressess C-fiber inputs to the rat superficial medullary dorsal horn via activation of GABA-B receptors. Eur J Neurosci 37:417-428
17. Micov A, Tomić M, Popović B, Stepanović- Petrović R (2010) The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action. Br J Pharmacol 161(2):384-392
18. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22(15):6724-6731
19. Pavone F, Luvisetto S (2010) Botulinum neurotoxin for pain management: insights from animal models. Toxins 2(12):2890-2913
20. Restani L, Antonucci F, Gianfranceschi L, Rossi C, Rossetto O, Caleo M (2011) Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A). J Neurosci 31(44):15650-15659
21. Tjølsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51(1):5-17
22. Ueda H, Amano H, Shiomi H, Takagi H (1979) Comparison of the analgesic effects of various opioid peptides by a newly devised intracisternal injection technique in conscious mice. Eur J Pharmacol 56:265-268
23. Yamamoto T, Yaksh TL (1993) Effects of intrathecal strychnine and bicuculline on nerve compression-induced thermal hyperalgesia and selective antagonism by MK-801. Pain 54(1):79-84